Masahiro Yamasaki Selected Research

4-dodecylaminophenol

10/2017

Anticancer efficacy of p-dodecylaminophenol against high-risk and refractory neuroblastoma cells in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masahiro Yamasaki Research Topics

Disease

27	Neoplasms (Cancer) 01/2024 - 07/2004
18	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 06/2006
13	Lung Neoplasms (Lung Cancer) 01/2024 - 01/2017
8	Carcinoma (Carcinomatosis) 10/2021 - 01/2005
6	Adenocarcinoma 01/2023 - 05/2004
6	Parasitemia 11/2019 - 03/2002
6	Infections 12/2018 - 03/2002
5	Hemorrhage 01/2022 - 05/2004
5	Disease Progression 10/2021 - 02/2007
5	Adenocarcinoma of Lung 01/2021 - 01/2017
4	Anemia 11/2019 - 03/2002
4	GM1 Gangliosidosis (Gangliosidosis GM1) 11/2011 - 02/2003
3	Brain Diseases (Brain Disorder) 01/2024 - 02/2002
3	Gallbladder Neoplasms (Gallbladder Cancer) 05/2023 - 04/2017
3	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2022 - 03/2018
3	Thymoma (Thymic Carcinoma) 01/2022 - 05/2017
3	Leukemia 01/2022 - 02/2017
3	Pneumonia (Pneumonitis) 01/2021 - 08/2019
3	Stomach Neoplasms (Stomach Cancer) 01/2017 - 07/2006
3	Bone Resorption 04/2016 - 05/2007
3	Obesity 04/2016 - 03/2009
3	Hemolysis 10/2014 - 12/2009
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2014 - 08/2011
3	Abscess 06/2012 - 04/2002
3	Hyperglycemia 01/2010 - 01/2004
3	Hyperplasia 01/2005 - 01/2002
2	Muscle Weakness 08/2022 - 01/2016
2	Respiratory Insufficiency (Respiratory Failure) 02/2022 - 09/2019
2	Venous Thromboembolism 01/2022 - 05/2021
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2017
2	Dermatomyositis (Dermatopolymyositis) 12/2020 - 03/2018
2	Organizing Pneumonia 11/2020 - 01/2020
2	Cryptococcosis 12/2019 - 01/2017
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2018 - 06/2010
2	Neuroblastoma 01/2018 - 10/2017
2	Hypertension (High Blood Pressure) 04/2017 - 03/2012
2	Acute Promyelocytic Leukemia 04/2017 - 01/2016
2	Polyps 11/2013 - 10/2013
2	AIDS-Related Complex (ARC) 03/2011 - 03/2009
2	Type 2 Diabetes Mellitus (MODY) 01/2010 - 05/2006
2	Body Weight (Weight, Body) 10/2009 - 07/2004

Drug/Important Bio-Agent (IBA)

8	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2017
8	Messenger RNA (mRNA)IBA 01/2022 - 03/2004
7	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022 - 01/2016
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 06/2006
7	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 06/2006
7	Proteins (Proteins, Gene)FDA Link 07/2016 - 01/2006
6	ErbB Receptors (EGF Receptor)IBA 02/2024 - 02/2018
5	Anti-Bacterial Agents (Antibiotics)IBA 05/2023 - 12/2009
5	Vitamin A (Retinol)FDA LinkGeneric 01/2022 - 01/2016
5	EnzymesIBA 03/2021 - 01/2004
4	pembrolizumabIBA 01/2022 - 08/2019
4	NivolumabIBA 01/2019 - 01/2017
4	Cisplatin (Platino)FDA LinkGeneric 10/2018 - 11/2008
4	acetoacetyl-CoA synthetaseIBA 01/2018 - 03/2009
4	CytokinesIBA 10/2014 - 10/2013
3	AnticoagulantsIBA 01/2024 - 05/2021
3	Tyrosine Kinase InhibitorsIBA 08/2022 - 02/2018
3	osimertinibIBA 08/2022 - 11/2019
3	Retinaldehyde (Retinal)IBA 01/2022 - 01/2016
3	KetonesIBA 04/2016 - 03/2009
3	SodiumIBA 12/2011 - 06/2005
3	Glucose (Dextrose)FDA LinkGeneric 12/2011 - 01/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2006 - 03/2002
2	Thiamine (Aneurin)FDA Link 04/2024 - 08/2022
2	CholesterolIBA 04/2024 - 03/2009
2	Prothrombin (Factor II)IBA 01/2023 - 01/2022
2	durvalumabIBA 12/2022 - 01/2020
2	Peptides (Polypeptides)IBA 01/2022 - 01/2017
2	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 01/2017
2	big gastrinIBA 01/2022 - 01/2017
2	edoxabanIBA 01/2022 - 05/2021
2	FenretinideIBA 01/2022 - 10/2017
2	Gefitinib (Iressa)FDA Link 10/2021 - 05/2021
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2021 - 05/2021
2	B7-H1 AntigenIBA 10/2021 - 08/2019
2	Gemcitabine FDA Link 01/2021 - 06/2006
2	PlatinumIBA 01/2021 - 08/2019
2	Indicators and Reagents (Reagents)IBA 01/2020 - 09/2004
2	AntibodiesIBA 09/2019 - 08/2011
2	Bevacizumab (Avastin)FDA Link 12/2018 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 04/2017 - 02/2007
2	Ketone BodiesIBA 04/2016 - 03/2009
2	Dacarbazine (DIC)FDA LinkGeneric 01/2015 - 11/2008
2	C-Reactive ProteinIBA 09/2014 - 03/2012
2	SonazoidIBA 01/2014 - 01/2012
2	Contrast MediaIBA 01/2014 - 01/2012
2	PotassiumIBA 12/2011 - 12/2009
2	Adenosine Triphosphate (ATP)IBA 12/2011 - 12/2009
2	G(M1) GangliosideIBA 11/2011 - 02/2007
2	Leukocyte Elastase (Neutrophil Elastase)IBA 12/2009 - 09/2008
2	CationsIBA 12/2009 - 05/2007
2	Adenosine Triphosphatases (ATPase)IBA 12/2009 - 12/2005

Therapy/Procedure

25	Therapeutics 01/2024 - 06/2006
10	Drug Therapy (Chemotherapy) 01/2021 - 06/2006
3	Chemoradiotherapy 12/2022 - 10/2009
3	Radiotherapy 01/2017 - 01/2007
2	General Anesthesia 02/2022 - 09/2014
2	Microbubbles 01/2014 - 01/2012
2	Combination Drug Therapy (Combination Chemotherapy) 09/2010 - 11/2008